Article Details

Analysts Conflicted on These Healthcare Names: Immutep Ltd (OtherPRRUF), Organon ...

Retrieved on: 2025-05-08 07:16:41

Tags for this article:

Click the tags to see associated articles and topics

Analysts Conflicted on These Healthcare Names: Immutep Ltd (OtherPRRUF), Organon .... View article details on hiswai:

Excerpt

The word on The Street in general, suggests a Strong Buy analyst consensus rating for BioNTech SE with a $141.53 average price target, a 40.4% upside ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo